AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...

Gasdermin C activation boosts type II immunity against helminths, and NSAIDs may someday offer a novel, repurposed treatment ...

VISTA, an AI-controlled data loop system, guides large-scale antibody design from scratch for applications in cancer therapy.

Three applications for gene editing in conservation are restoring lost variation and facilitated adaptation as well as reducing harmful mutations.

Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.

An antibody treatment successfully prepared patients for stem cell transplants without toxic chemotherapy or radiation.